Parmax Pharma Ltd
Parmax Pharma Ltd
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | 4.33 | 2.54 | 1.95 |
| Operating Expense | 4.52 | 4.12 | 2.19 |
| Net Profit | -0.73 | -2.08 | -0.76 |
| Net Profit Margin | -16.86% | -81.89% | -38.97% |
| Earning Per Share | -1.96 | -5.56 | -2.04 |
| EBIDTA | -0.18 | -1.58 | -0.24 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Dec 2025
Revenue4.33
Operating Expense4.52
Net Profit-0.73
Net Profit Margin-16.86
Earning Per Share-1.96
EBIDTA-0.18
Effective Tax Rate-0
